Risk of adenocarcinoma in Barrett's oesophagus: population based study.
作者信息
Murray Liam, Watson Peter, Johnston Brian, Sloan James, Mainie Inder Mohan Lal, Gavin Anna
机构信息
Northern Ireland Cancer Registry, Department of Epidemiology and Public Health, Queen's University of Belfast, Belfast BT12 6BJ.
出版信息
BMJ. 2003 Sep 6;327(7414):534-5. doi: 10.1136/bmj.327.7414.534.
Abstract
摘要
相似文献
1
Risk of adenocarcinoma in Barrett's oesophagus: population based study.巴雷特食管腺癌的风险：基于人群的研究。
BMJ. 2003 Sep 6;327(7414):534-5. doi: 10.1136/bmj.327.7414.534.
2
The incidence of adenocarcinoma and dysplasia in Barrett's esophagus: report on the Cleveland Clinic Barrett's Esophagus Registry.巴雷特食管腺癌和发育异常的发病率：克利夫兰诊所巴雷特食管登记处报告
Am J Gastroenterol. 1999 Aug;94(8):2037-42. doi: 10.1111/j.1572-0241.1999.01275.x.
3
Risk of malignant progression in patients with Barrett's oesophagus: a Dutch nationwide cohort study.巴雷特食管患者发生恶性进展的风险：一项荷兰全国性队列研究。
Gut. 2010 Aug;59(8):1030-6. doi: 10.1136/gut.2009.176701.
4
Barrett's esophagus and cancer risk: a more realistic estimate.巴雷特食管和癌症风险：更现实的估计。
Semin Thorac Cardiovasc Surg. 2011 Winter;23(4):261-2. doi: 10.1053/j.semtcvs.2012.01.003.
5
Dysplasia and risk of further neoplastic progression in a regional Veterans Administration Barrett's cohort.一个地区退伍军人管理局巴雷特食管队列中的发育异常及进一步肿瘤进展风险
Am J Gastroenterol. 2005 Apr;100(4):775-83. doi: 10.1111/j.1572-0241.2005.41300.x.
6
Dysplasia in short-segment Barrett's esophagus: a prospective 3-year follow-up.短节段巴雷特食管的发育异常：一项为期3年的前瞻性随访研究
Am J Gastroenterol. 1997 Nov;92(11):2012-6.
7
Progress in outlining the frequency and risk of recurrent neoplasia after ablation of Barrett's esophagus.巴雷特食管消融术后复发性肿瘤形成的频率和风险概述方面的进展。
Gastrointest Endosc. 2010 Apr;71(4):704-5. doi: 10.1016/j.gie.2009.12.027.
8
Surveillance in Barrett's oesophagus: will a strategy focused on a high-risk group reduce mortality from oesophageal adenocarcinoma?巴雷特食管的监测：针对高危人群的策略能否降低食管腺癌的死亡率？
Endoscopy. 2006 Feb;38(2):162-9. doi: 10.1055/s-2005-921184.
9
Barrett's esophagus: a new look at surveillance based on emerging estimates of cancer risk.巴雷特食管：基于新出现的癌症风险估计对监测的新认识。
Am J Gastroenterol. 1999 Aug;94(8):2043-53. doi: 10.1111/j.1572-0241.1999.01276.x.
10
Long-term endoscopic surveillance of patients with Barrett's esophagus. Incidence of dysplasia and adenocarcinoma: a prospective study.巴雷特食管患者的长期内镜监测。发育异常和腺癌的发病率：一项前瞻性研究。
Am J Gastroenterol. 2003 Sep;98(9):1931-9. doi: 10.1111/j.1572-0241.2003.07666.x.
引用本文的文献
1
Esophageal abnormalities and the risk for gastroesophageal cancers-a histopathology-register-based study in Sweden.食管异常与胃食管交界癌风险——基于瑞典病理登记的研究
Eur J Epidemiol. 2022 Apr;37(4):401-411. doi: 10.1007/s10654-021-00833-6. Epub 2022 Jan 3.
2
Barrett's Esophagus and Intestinal Metaplasia.巴雷特食管与肠化生
Front Oncol. 2021 Jun 17;11:630837. doi: 10.3389/fonc.2021.630837. eCollection 2021.
3
Prospective evaluation of the clinical utility of endoscopic submucosal dissection (ESD) in patients with Barrett's esophagus: a Western center experience.巴雷特食管患者内镜黏膜下剥离术（ESD）临床效用的前瞻性评估：一家西方中心的经验
Endosc Int Open. 2016 Jun;4(6):E715-21. doi: 10.1055/s-0042-101788. Epub 2016 Mar 30.
4
Barrett's esophagus in 2016: From pathophysiology to treatment.2016年的巴雷特食管：从病理生理学到治疗
World J Gastrointest Pharmacol Ther. 2016 May 6;7(2):190-206. doi: 10.4292/wjgpt.v7.i2.190.
5
Delivering a research-enabled multistakeholder partnership for enhanced patient care at a population level: The Northern Ireland Comprehensive Cancer Program.在人群层面构建基于研究的多利益相关方伙伴关系以加强患者护理：北爱尔兰综合癌症项目
Cancer. 2016 Mar 1;122(5):664-73. doi: 10.1002/cncr.29814. Epub 2015 Dec 22.
6
A pilot study of the endomicroscopic assessment of tumor extension in Barrett's esophagus-associated neoplasia before endoscopic resection.内镜下切除术前对巴雷特食管相关肿瘤中肿瘤浸润进行内镜显微镜评估的一项试点研究。
Endosc Int Open. 2015 Feb;3(1):E19-28. doi: 10.1055/s-0034-1377935. Epub 2014 Oct 24.
7
Expression of SOX9 and CDX2 in nongoblet columnar-lined esophagus predicts the detection of Barrett's esophagus during follow-up.SOX9 和 CDX2 在无肠型柱状上皮食管中的表达可预测 Barrett 食管在随访中的检出。
Mod Pathol. 2015 May;28(5):654-61. doi: 10.1038/modpathol.2014.157. Epub 2014 Nov 21.
8
Nonsteroidal anti-inflammatory drugs and the risk of Barrett's esophagus.非甾体抗炎药与巴雷特食管的风险。
Clin Gastroenterol Hepatol. 2014 Nov;12(11):1832-9.e6. doi: 10.1016/j.cgh.2014.04.027. Epub 2014 Apr 30.
9
Endoscopic ultrasound in Barrett's oesophagitis with dysplasia.内镜超声在伴有发育异常的巴雷特食管炎中的应用
Ulster Med J. 2012 May;81(2):70-3.
10
Screening for oesophageal cancer.食管癌筛查
Cochrane Database Syst Rev. 2012 Dec 12;12(12):CD007883. doi: 10.1002/14651858.CD007883.pub2.
本文引用的文献
1
Secular trends in the epidemiology and outcome of Barrett's oesophagus in Olmsted County, Minnesota.明尼苏达州奥尔姆斯特德县巴雷特食管的流行病学及转归的长期趋势
Gut. 2001 Mar;48(3):304-9. doi: 10.1136/gut.48.3.304.
2
Final results from 10 year cohort of patients undergoing surveillance for Barrett's oesophagus: observational study.对巴雷特食管患者进行10年随访的最终结果：观察性研究。
BMJ. 2000 Nov 18;321(7271):1252-5. doi: 10.1136/bmj.321.7271.1252.
3
Is there publication bias in the reporting of cancer risk in Barrett's esophagus?巴雷特食管癌症风险报告中是否存在发表偏倚？
Gastroenterology. 2000 Aug;119(2):333-8. doi: 10.1053/gast.2000.9302.
4
Management of Barrett's esophagus: a national study of practice patterns and their cost implications.巴雷特食管的管理：一项关于实践模式及其成本影响的全国性研究。
Am J Gastroenterol. 1999 Dec;94(12):3440-7. doi: 10.1111/j.1572-0241.1999.01606.x.
5
Barrett's esophagus: a new look at surveillance based on emerging estimates of cancer risk.巴雷特食管：基于新出现的癌症风险估计对监测的新认识。
Am J Gastroenterol. 1999 Aug;94(8):2043-53. doi: 10.1111/j.1572-0241.1999.01276.x.
Zotero 插件